Electris360: Powering Up for 2026–What’s Really Driving the Electrical Supply Chain

HIAWATHA, Iowa, Jan. 22, 2026 (GLOBE NEWSWIRE) — As infrastructure investment accelerates across North America, the electrical industry is entering a critical planning cycle. Demand is strong, project pipelines are full, and capital continues to flow. Yet for many manufacturers, growth is proving harder to convert into results. The reason is not demand, it is […]

Ardent Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ardent Health, Inc. – ARDT

(NYSE:ARDT), NEW ORLEANS, Jan. 22, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company's securities between

Presidio Completes Acquisition of Ergo

DUBLIN, Jan. 22, 2026 (GLOBE NEWSWIRE) — Presidio, a leading global technology services and solutions provider, today announced that it has completed its acquisition of Ergo, the Ireland-headquartered IT solutions and managed services provider. The acquisition marks an important milestone for Presidio's European growth strategy, combining two complementary industry leaders to expand digital transformation capabilities

Electris360: Powering Up for 2026–What’s Really Driving the Electrical Supply Chain

Electris360: Powering Up for 2026–What's Really Driving the Electrical Supply Chain Manufacturers face strong demand, rising execution friction, and a rapidly evolving sales channel as they plan for the next cycle. GlobeNewswire January 22, 2026 HIAWATHA, Iowa, Jan. 22, 2026 (GLOBE NEWSWIRE) — As infrastructure investment accelerates across North America, the electrical industry is entering

Ardent Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ardent Health, Inc. – ARDT

Ardent Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ardent Health, Inc. – ARDT GlobeNewswire January 22, 2026 NEW ORLEANS, Jan. 22, 2026 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 9, 2026 to

Presidio Completes Acquisition of Ergo

Presidio Completes Acquisition of Ergo Building on a strong foundation to unite exceptional teams and create a scalable platform for growth across Europe GlobeNewswire January 22, 2026 DUBLIN, Jan. 22, 2026 (GLOBE NEWSWIRE) — Presidio, a leading global technology services and solutions provider, today announced that it has completed its acquisition of Ergo, the Ireland-headquartered

New Crypto Mutuum Finance (MUTM) to Share V1 Protocol Updates Next Week

DUBAI, United Arab Emirates, Jan. 22, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) says it has reached $19.8 million raised in its presale and is now applying the final touches to the protocol ahead of launch. In recent X updates, the team confirmed the completion of Halborn Security's independent audit of its V1 lending and

New Crypto Mutuum Finance (MUTM) to Share V1 Protocol Updates Next Week

New Crypto Mutuum Finance (MUTM) to Share V1 Protocol Updates Next Week GlobeNewswire January 22, 2026 DUBAI, United Arab Emirates, Jan. 22, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) says it has reached $19.8 million raised in its presale and is now applying the final touches to the protocol ahead of launch. In recent X

PhaseV Demonstrates How AI-Driven Site Selection and Real-Time Analytics Reduce Recruitment Uncertainty and Accelerate IBD Clinical Trials

Poster Presentation at the 2026 Crohn’s & Colitis Congress® Showcases Use of Causal Machine Learning and IBD Plexus® to Optimize Trial Execution PhaseV, a leader in AI/ML for clinical development, is today presenting new study results demonstrating its ability to improve inflammatory bowel disease (IBD) trial efficiency at the 2026 Crohn’s & Colitis Congress in

Scroll to Top